© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the official source for authoritative text.
Commonwealth legislation
This Act has been repealed and is no longer in force. It is retained for historical reference.
What this instrument does, mechanically
Creates two national drug-testing schemes that apply to all people the Act defines as "competitors": Scheme A and Scheme B (reg 6; reg 7A). The detailed operational rules for each scheme are set partly in these Regulations and partly in separate "Orders" the Agency may make (reg 6(3); reg 7A(3); reg 7; reg 7B).
Gives the Australian Sports Drug Agency (the Agency) powers to locate competitors, require them to provide information about where they can be found (a "whereabouts" request) and to ask competitors to give bodily samples for testing (regs 13A; 17; 15). The Agency may also ask sporting administration bodies to arrange testing when a competitor is under another body’s jurisdiction (see paragraph 17ZC of the Act referred to throughout the Regulations; regs 49, 49G).
Sets procedures for sample collection, testing and contesting test results. The Agency may screen samples itself and may ask accredited laboratories to carry out tests (regs 23–24). Samples are split into Part A and Part B; a competitor normally gets notice and short timeframes to elect Part B testing and to make written submissions on validity (regs 42–48; regs 52–58).
Establishes a Register of Notifiable Events for each scheme. The Agency must enter failures to comply with whereabouts requests, failures to provide samples, deliberate evasion, tampering and positive test results, after considering any submissions from the competitor (regs 26–31; regs 27–30). When an entry is made the Agency must notify relevant national sporting organisations, sporting organisations and relevant government agencies (reg 31). Removal or correction of entries is provided for in specified circumstances (regs 34–35; regs 34A–34B; reg 34B).
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in Australian Sports Drug Agency Regulations 1999.
Zoe has indexed the source text for search and analysis. Use the official register for the original document and download formats.
View on official registerSourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
Specifies competitors’ procedural rights: how and when they are to be given notice, opportunities to make written submissions (typically within 7 days), rights to a representative or interpreter, rights to be present or represented at testing of Part B, and limited exceptions to sample requests (regs 36–48; regs 49–58; regs 17–19; reg 38; reg 46; reg 56).
Gives functions to the Australian Sports Drug Medical Advisory Committee (ASDMAC): it may investigate positive results, grant therapeutic use approvals, disclose certain information to competitors and sporting bodies, and participate in reviews or appeals of its decisions (reg 64).
Authorises the Agency to approve couriers and to prescribe courier services for sending notices and samples; it sets application, approval, cancellation and review procedures for couriers (regs 71–80; reg 86). It also prescribes an organisation (NATA) that may recognise accredited laboratories (reg 84).
Provides internal administrative rules: identity cards for Agency representatives, conflict-of-interest reporting requirements, delegation of powers to Agency staff and officials, notice rules (when a written notice is treated as received), privacy note for register information, and rules about disclosure to sporting bodies and public release (regs 8–12; reg 81–83; reg 26 note; regs 63B–63C; reg 83; reg 10).
Who this affects, in practice
Competitors (people covered by the Act) are the primary subjects: they can be required to provide whereabouts information and bodily samples; they face possible entries on a public register and have time-limited procedural rights to respond (regs 6; 13A; 17; regs 26–31; regs 36–48).
The Agency and ASDMAC (administrative decision‑makers) gain operational powers to request samples, manage testing, maintain registers, approve couriers and delegate tasks to officials and chaperones (regs 7; 15; 23–25; regs 26–35; regs 71–82; regs 8–9).
Accredited laboratories, specified courier services and named organisations recognised under the Regulations (e.g. National Association of Testing Authorities) are placed in designated roles (reg 24; reg 84; reg 86).
Sporting administration bodies are operational partners when the Agency asks them to arrange testing overseas or in other circumstances; they must require conflict-of-interest reporting of their representatives (reg 13; reg 49; reg 49G).
Why it matters (official claim, then an analytical check)
Officially: the Reader’s Guide states the Regulations set out procedural and operational details for drug testing schemes so the Agency can detect use of scheduled drugs and doping methods, arrange testing, keep records (Register of Notifiable Events) and protect procedural rights of competitors (Reader’s Guide; regs 5; reg 6; reg 7A; regs 26–31; Div 2.6).
Analytical check against costs, incentives and trade-offs (source‑grounded):
Concentrated benefits, diffuse costs and potential pressure points (source‑grounded mechanisms)
Concentrated benefits to specific private entities arise where the Regulations list or prescribe named organisations (e.g. courier services in reg 86; accredited-recognition organisation in reg 84). The mechanism is explicit naming and prescription of services.
Diffuse costs fall on the wider population of competitors who must meet whereabouts and sample obligations and the short procedural timeframes for submissions in the event of alleged non‑compliance or a positive result (see regs 13A; 17; regs 36A–36F; regs 40–48).
The Agency’s power to enter information on a register and to share information with sporting bodies and government agencies (regs 27–33; reg 31; regs 63B–63C) concentrates decision authority in the Agency and ASDMAC while providing competitors formal review rights (right to apply to the Administrative Appeals Tribunal — reg 61).
Bottom line (neutral mechanics): the Regulations set a nationwide administrative framework for anti‑doping testing and dispute-handling. They create mandatory administrative steps for competitors (whereabouts, samples and time-limited submissions), procedural safeguards (notice, representation, Part B testing), institutional roles for the Agency and ASDMAC (testing, investigations, therapeutic approvals), and operational rules for laboratories, couriers and registers (regs 6; 15–25; regs 26–48; regs 64; regs 71–86). These mechanisms allocate enforcement authority and set the compliance costs and procedural protections that govern how testing and follow-up are managed.